Sequent Scientific posts Rs 30.53 crore profit for Q2
New Delhi: Drug firm Sequent Scientific reported a consolidated net profit of Rs 30.53 crore for the quarter ending September 30.
The company had posted a net loss of Rs 4.44 crore for the corresponding period of the previous fiscal, Sequent Scientific said in a filing to BSE.
Consolidated total income of the company stood at Rs 271.93 crore for the quarter under consideration as compared to Rs 232.79 crore for the same period previous fiscal.
In a separate filing, the company said its board has declared an interim dividend of Rs 0.20 per equity share of Rs 2 each.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd